As of this month, about 37 percent of adults 18 and older had received a seasonal flu shot, while 19 percent had received ...

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.

GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

it is also important to talk with your doctor and stay up to date on vaccines for pneumococcal disease, flu, RSV, and COVID-19. PNEUMOCOCCAL DISEASEPneumococcal disease is caused by bacteria that ...

We’re about six weeks out from when acute respiratory illness-related hospitalizations peaked in Illinois last year.

With RSV activity continuing to rise above normal levels, Boots has become the first high street pharmacy chain to offer a ...

Planning to gather for Thanksgiving with family and friends? Both the Green Bay Packers and Detroit Lions are playing that day, so there’s an extra incentive to settle down with a crowd post-meal to ...

Despite more than 50 years of research, there are no RSV vaccines approved or in Phase III clinical trials. Key challenges include peak disease in infants less than 3 months of age and ...

RSV vaccines for babies and pregnant women were added to the free National Immunisation Program this week. Cases of the infection spiked earlier this year, up 40 per cent on the previous year in ...

With flu, respiratory syncytial virus (RSV), and COVID-19 cases starting to rise, officials say now is the time to get a vaccine.